Atomica's new Biotechnology Microdevices Platform helps accelerate the development of diagnostic, drug delivery, and medical research devices so promising healthcare technologies can reach patients sooner. It combines established microfabrication modules, custom design flexibility, and engineering collaboration to support customers from feasibility through scalable production.
SANTA BARBARA, Calif., Oct. 6, 2026 /PRNewswire-PRWeb/ -- Atomica, a U.S.-based microfabrication foundry, today announced the launch of its Biotechnology Microdevices Platform, the seventh in its portfolio of application-focused platforms.
"Patients need these breakthroughs, but developing the devices behind them can take years," said Eldon Klaassen, CEO of Atomica. "Our role is to help innovators overcome the engineering and manufacturing barriers that keep promising ideas in the laboratory. Every development hurdle we help resolve brings those technologies a step closer to improving care."
The platform supports diagnostic technologies for cancer, infectious disease, and genetic analysis, including compact chips used in testing cartridges. By integrating sample preparation and detection functions, these devices can help developers bring more testing to clinics and other points of need, where timely answers can guide care.
For drug delivery, the platform supports microneedle arrays and related structures for minimally invasive delivery and sampling. These components can be combined with reservoirs and fluid controls in devices designed to reduce the burden of conventional administration and support new approaches to treatment.
The platform also supports the tools behind future therapies. Cell-analysis chips, microarrays, and organ-on-chip systems allow researchers to study biological responses in controlled environments. Wearable and implantable sensing structures extend its applications into medical monitoring.
The platform spans five device families: microfluidics, microneedles, microarrays, sensors and diaphragms, and packaging and integration. Customers can build on established processes and add features suited to their diagnostic method, therapy, or research application. This foundation helps reduce the process development work required while preserving room for product innovation.
Atomica's engineers work with customers to evaluate fabrication, packaging, testing, and connections to the rest of the product. Addressing these requirements early helps avoid costly redesigns and delays as devices move beyond the laboratory. That collaboration continues from feasibility work and engineering samples through functional prototypes, qualification, and scalable production.
The Biotechnology Microdevices Platform expands Atomica's portfolio of recently launched platforms, joining AI Optical Connectivity,AI Optical Source, AI Photonic Integration, AI Thermal Microstructures, Physical AI Sensor, and MEMS Optical Control. Together, these platforms give customers access to established microfabrication capabilities tailored to the needs of advanced hardware applications.
Learn more about the platform and download the accompanying eBook at: https://atomica.com/biotech-microdevices-platform/
About Atomica
Atomica is a U.S.-based microfabrication foundry that builds advanced platforms for AI hardware, photonics, sensors, MEMS, and biotechnology devices.
Atomica delivers rapid prototyping and scalable production to customers developing AI optical connectivity, AI optical source integration, AI photonic integration, AI thermal microstructures, physical AI sensors, MEMS optical control systems, and biotechnology microdevices.
Atomica operates a 30,000-square-foot Class 100 cleanroom near Santa Barbara, California, supporting a wide range of capabilities and materials with ISO 9001 certification and ITAR registration. Capabilities include photolithography, deposition, dry etch, wet etch, bonding, plating, metrology, testing, dicing, and planarization.
Atomica leverages engineering collaboration, process standardization, modeling and simulation, AI-assisted optimization, and proprietary fab technology to achieve customer objectives.
Media Contact
Stephen Bohn, Atomica Corp., 1 805-696-6181, [email protected], atomica.com
SOURCE Atomica Corp.
Share this article